| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T20 |
0-265 |
Sentence |
denotes |
For COVID-19 patients who develop ARDS requiring intubation and mechanical ventilation, shock and multiple organ failure can also develop, although whether this is a direct consequence of viral infection or due to complications of critical illness is not yet clear. |
| T21 |
266-382 |
Sentence |
denotes |
Current therapeutic approaches include aggressive standard supportive care and treatment of any other co-infections. |
| T22 |
383-579 |
Sentence |
denotes |
Antiviral medications, including remdesivir, lopinavir–ritonavir, or lopinavir–ritonavir and interferon (IFN)-β1, are under investigation but safety and potential efficacy remain to be determined. |
| T23 |
580-816 |
Sentence |
denotes |
Remdesivir and IFN-β1β appear to have superior antiviral activity to lopinavir and remdesivir in vitro for the Middle East respiratory syndrome (MERS) coronavirus but whether this is the case for SARS-CoV-2 remains to be determined [2]. |
| T24 |
817-970 |
Sentence |
denotes |
The US Food and Drug Administration (FDA) has recently approved use of hydroxychloroquine in COVID-19 patients but the efficacy remains to be determined. |
| T25 |
971-1189 |
Sentence |
denotes |
Growing information also suggests that virus-induced cytokine storm in the lungs may drive severe pathogenesis and provide potential therapeutic targets, for example anti-interleukin (IL)-6 or anti-IL-1 approaches [3]. |
